Differential diagnosis of major depressive disorder versus bipolar disorder: Current status and best clinical practices

Roger S. McIntyre; Mark Zimmerman; Joseph F. Goldberg; Michael B. First

doi:10.4088/JCP.OT18043AH2

Differential diagnosis of major depressive disorder versus bipolar disorder: Current status and best clinical practices

Roger S. McIntyre
, Mark Zimmerman
, Joseph F. Goldberg
, Michael B. First

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Original language	English
Article number	ot18043ah2
Pages (from-to)	15-24
Number of pages	10
Journal	Journal of Clinical Psychiatry
Volume	80
Issue number	3
DOIs	https://doi.org/10.4088/JCP.OT18043AH2
State	Published - 2019

Access to Document

10.4088/JCP.OT18043AH2

Cite this

@article{363c142800774cc2be4312ff7f948afe,

title = "Differential diagnosis of major depressive disorder versus bipolar disorder: Current status and best clinical practices",

author = "McIntyre, \{Roger S.\} and Mark Zimmerman and Goldberg, \{Joseph F.\} and First, \{Michael B.\}",

note = "Funding Information: or grants from private industries or nonprofit funds from Stanley Medical Research Institute and CIHR/GACD/ Chinese National Natural Research Foundation and has received consultant/speaker fees from Lundbeck, Janssen, Shire, Purdue, Pfizer, Otsuka, Allergan, Takeda, Neurocrine, Sunovion, and Minerva. Dr Zimmerman has received consultant fees from Otsuka and Praxis Precision Medicines and has served on a speaker/advisory board for Alkermes. Dr Goldberg has received consultant fees from Lundbeck, Neurocrine, Otsuka, Sunovion, and WebMD and has served on speaker/advisory boards for Allergan, Neurocrine, Otsuka, Sunovion, and Takeda-Lundbeck. Dr First has received consultant fees as a member of the faculty of the Lundbeck International Neuroscience Foundation.",

year = "2019",

doi = "10.4088/JCP.OT18043AH2",

language = "English",

volume = "80",

pages = "15--24",

journal = "Journal of Clinical Psychiatry",

issn = "0160-6689",

publisher = "Physicians Postgraduate Press Inc.",

number = "3",

}

TY - JOUR

T1 - Differential diagnosis of major depressive disorder versus bipolar disorder

T2 - Current status and best clinical practices

AU - McIntyre, Roger S.

AU - Zimmerman, Mark

AU - Goldberg, Joseph F.

AU - First, Michael B.

N1 - Funding Information: or grants from private industries or nonprofit funds from Stanley Medical Research Institute and CIHR/GACD/ Chinese National Natural Research Foundation and has received consultant/speaker fees from Lundbeck, Janssen, Shire, Purdue, Pfizer, Otsuka, Allergan, Takeda, Neurocrine, Sunovion, and Minerva. Dr Zimmerman has received consultant fees from Otsuka and Praxis Precision Medicines and has served on a speaker/advisory board for Alkermes. Dr Goldberg has received consultant fees from Lundbeck, Neurocrine, Otsuka, Sunovion, and WebMD and has served on speaker/advisory boards for Allergan, Neurocrine, Otsuka, Sunovion, and Takeda-Lundbeck. Dr First has received consultant fees as a member of the faculty of the Lundbeck International Neuroscience Foundation.

PY - 2019

Y1 - 2019

UR - https://www.scopus.com/pages/publications/85066851443

U2 - 10.4088/JCP.OT18043AH2

DO - 10.4088/JCP.OT18043AH2

M3 - Article

C2 - 31091027

AN - SCOPUS:85066851443

SN - 0160-6689

VL - 80

SP - 15

EP - 24

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

IS - 3

M1 - ot18043ah2

ER -